Characteristics of gadolinium-based contrast media cancellation at the point of care: a 15-month assessment of FDA-inspired medication guides on gadolinium retention.
Laura S O'DonohuePrasad R ShankarErica B SteinMatthew S DavenportPublished in: Abdominal radiology (New York) (2020)
FDA-inspired handouts informing patients about gadolinium retention did not significantly change the frequency of GBCM cancellation. GBCM cancellations at the point of care remain uncommon.